Biolidics

Biolidics Limited ("Biolidics" or the "Company"), established in 2009 and listed on the Singapore Stock Exchange, is a medical technology company focused on the development of cell enrichment systems. The system, combined with other analytical tests, can be widely applied in cancer diagnosis, prognosis, treatment selection, and therapeutic monitoring.